These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 33647576
1. HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome. Mtshali A, Ngcapu S, Mindel A, Garrett N, Liebenberg L. J Reprod Immunol; 2021 Jun; 145():103291. PubMed ID: 33647576 [Abstract] [Full Text] [Related]
2. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis. Mtshali A, San JE, Osman F, Garrett N, Balle C, Giandhari J, Onywera H, Mngomezulu K, Mzobe G, de Oliveira T, Rompalo A, Mindel A, Abdool Karim SS, Ravel J, Passmore JS, Abdool Karim Q, Jaspan HB, Liebenberg LJP, Ngcapu S. Front Immunol; 2021 Jun; 12():730986. PubMed ID: 34594336 [Abstract] [Full Text] [Related]
7. Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection. Masson L, Arnold KB, Little F, Mlisana K, Lewis DA, Mkhize N, Gamieldien H, Ngcapu S, Johnson L, Lauffenburger DA, Abdool Karim Q, Abdool Karim SS, Passmore JA. Sex Transm Infect; 2016 May; 92(3):186-93. PubMed ID: 26511781 [Abstract] [Full Text] [Related]
8. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility. Joag V, Obila O, Gajer P, Scott MC, Dizzell S, Humphrys M, Shahabi K, Huibner S, Shannon B, Tharao W, Mureithi M, Oyugi J, Kimani J, Kaushic C, Ravel J, Anzala O, Kaul R. Clin Infect Dis; 2019 May 02; 68(10):1675-1683. PubMed ID: 30407498 [Abstract] [Full Text] [Related]
9. Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women. Garrett N, Mtshali A, Osman F, Masson L, McKinnon LR, Singh R, Mitchev N, Ngobese H, Kharsany ABM, Abdool Karim S, Mlisana K, Passmore JA, Rompalo A, Mindel A, Liebenberg L. Sex Transm Infect; 2021 Dec 02; 97(8):555-565. PubMed ID: 33608480 [Abstract] [Full Text] [Related]
11. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility. Mohammadi A, Bagherichimeh S, Perry MC, Fazel A, Tevlin E, Huibner S, Tharao W, Coburn B, Kaul R. Sci Rep; 2020 May 22; 10(1):8514. PubMed ID: 32444843 [Abstract] [Full Text] [Related]
12. Mechanisms of sexually transmitted infection-induced inflammation in women: implications for HIV risk. Mwatelah R, McKinnon LR, Baxter C, Abdool Karim Q, Abdool Karim SS. J Int AIDS Soc; 2019 Aug 22; 22 Suppl 6(Suppl Suppl 6):e25346. PubMed ID: 31468677 [Abstract] [Full Text] [Related]
13. Bacterial vaginosis and the cervicovaginal immune response. Mitchell C, Marrazzo J. Am J Reprod Immunol; 2014 Jun 22; 71(6):555-63. PubMed ID: 24832618 [Abstract] [Full Text] [Related]
14. Genital inflammation, immune activation and risk of sexual HIV acquisition. Passmore JA, Jaspan HB, Masson L. Curr Opin HIV AIDS; 2016 Mar 22; 11(2):156-62. PubMed ID: 26628324 [Abstract] [Full Text] [Related]
15. Genital tract interleukin-8 but not interleukin-1beta or interleukin-6 concentration is associated with bacterial vaginosis and its clearance in HIV-infected and HIV-uninfected women. Losikoff P, Fichorova R, Snyder B, Rodriguez I, Cu-Uvin S, Harwell J, Mayer KH. Infect Dis Obstet Gynecol; 2007 Mar 22; 2007():92307. PubMed ID: 18273408 [Abstract] [Full Text] [Related]
16. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C, Passmore JA, Grobler AC, Sturm AW, Williamson C, Ronacher K, Walzl G, Abdool Karim SS. J Infect Dis; 2012 Jul 01; 206(1):6-14. PubMed ID: 22517910 [Abstract] [Full Text] [Related]
17. Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women. Mngomezulu K, Mzobe GF, Mtshali A, Osman F, Liebenberg LJP, Garrett N, Singh R, Rompalo A, Mindel A, Karim SSA, Karim QA, Baxter C, Ngcapu S. Front Immunol; 2021 Jul 01; 12():695201. PubMed ID: 34177961 [Abstract] [Full Text] [Related]
18. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention. Kyongo JK, Crucitti T, Menten J, Hardy L, Cools P, Michiels J, Delany-Moretlwe S, Mwaura M, Ndayisaba G, Joseph S, Fichorova R, van de Wijgert J, Vanham G, Ariën KK, Jespers V. Clin Vaccine Immunol; 2015 May 01; 22(5):526-38. PubMed ID: 25761460 [Abstract] [Full Text] [Related]
19. Relationship between female genital tract infections, mucosal interleukin-17 production and local T helper type 17 cells. Masson L, Salkinder AL, Olivier AJ, McKinnon LR, Gamieldien H, Mlisana K, Scriba TJ, Lewis DA, Little F, Jaspan HB, Ronacher K, Denny L, Abdool Karim SS, Passmore JA. Immunology; 2015 Dec 01; 146(4):557-67. PubMed ID: 26302175 [Abstract] [Full Text] [Related]
20. Cost-effectiveness analysis of different screening and diagnostic strategies for sexually transmitted infections and bacterial vaginosis in women attending primary health care facilities in Cape Town. Smith E, Masson L, Passmore JS, Sinanovic E. Front Public Health; 2023 Dec 01; 11():1048091. PubMed ID: 36935688 [Abstract] [Full Text] [Related] Page: [Next] [New Search]